Transcription of 2 QUALITATIVE AND QUANTITATIVE …
{{id}} {{{paragraph}}}
New Zealand Datasheet 1 PRODUCT NAME GINET 2 qualitative and quantitative COMPOSITION Each tablet contains Cyproterone Acetate mg and Ethinylestradiol Tablets 35 mcg. 3 PHARMACEUTICAL FORM Each blister tray contains 21 yellow active tablets and 7 larger white inactive tablets. Each active tablet is a yellow, biconvex, film-coated tablet, containing cyproterone acetate 2 mg and ethinylestradiol 35 micrograms ( mg) with a diameter of mm. Each inactive tablet is a white, round, biconvex, tablet, plain on both sides with a diameter of mm. 4 CLINICAL PARTICULARS Therapeutic indications Androgen-dependent diseases in women are an indication for treatment with GINET.
New Zealand Datasheet 1 PRODUCT NAME GINET 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains Cyproterone Acetate 2.00 mg and Ethinylestradiol Tablets 35 mcg.
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}